ASH 2024: ADC Post-Conference Report

Our ADC experts have screened the abstracts presented at the 66th ASH Annual Meeting, held in San Diego from the 7th to 10th of December 2024, and identified 106 abstracts (90 clinical and 16 preclinical) associated with records on Beacon ADC. These have been analyzed and listed in our Post-Conference Report.

ASH 2024: ADC Abstract Highlights

This post-conference report sample provides a guide to the ADC-relevant abstracts presented at the 2024 ASH Annual Meeting.

Explore a list of each abstract with information on developmental phase, target, asset, disease indication, trial sponsor, and more. Download your free copy today.

You May Also Be Interested In…

Learn More About ADC

What is Beacon ADC?
  • The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
  • Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon ADC

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search